Correlation Between Assertio Therapeutics and Intracellular
Can any of the company-specific risk be diversified away by investing in both Assertio Therapeutics and Intracellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assertio Therapeutics and Intracellular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assertio Therapeutics and Intracellular Th, you can compare the effects of market volatilities on Assertio Therapeutics and Intracellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assertio Therapeutics with a short position of Intracellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assertio Therapeutics and Intracellular.
Diversification Opportunities for Assertio Therapeutics and Intracellular
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Assertio and Intracellular is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Assertio Therapeutics and Intracellular Th in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intracellular Th and Assertio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assertio Therapeutics are associated (or correlated) with Intracellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intracellular Th has no effect on the direction of Assertio Therapeutics i.e., Assertio Therapeutics and Intracellular go up and down completely randomly.
Pair Corralation between Assertio Therapeutics and Intracellular
Given the investment horizon of 90 days Assertio Therapeutics is expected to under-perform the Intracellular. In addition to that, Assertio Therapeutics is 2.12 times more volatile than Intracellular Th. It trades about -0.03 of its total potential returns per unit of risk. Intracellular Th is currently generating about 0.21 per unit of volatility. If you would invest 7,502 in Intracellular Th on August 24, 2024 and sell it today you would earn a total of 1,043 from holding Intracellular Th or generate 13.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Assertio Therapeutics vs. Intracellular Th
Performance |
| Timeline |
| Assertio Therapeutics |
| Intracellular Th |
Assertio Therapeutics and Intracellular Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Assertio Therapeutics and Intracellular
The main advantage of trading using opposite Assertio Therapeutics and Intracellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assertio Therapeutics position performs unexpectedly, Intracellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will offset losses from the drop in Intracellular's long position.| Assertio Therapeutics vs. Amneal Pharmaceuticals, Class | Assertio Therapeutics vs. Lifecore Biomedical | Assertio Therapeutics vs. Ironwood Pharmaceuticals | Assertio Therapeutics vs. Neurocrine Biosciences |
| Intracellular vs. Alkermes Plc | Intracellular vs. Ironwood Pharmaceuticals | Intracellular vs. Pacira BioSciences, | Intracellular vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |